Read the Registration Document - Guerbet

More documents

Recommendations

Info

5) Group organisation at 31 December 2012a) Executive CommitteeYves L’Epine – Chief Executive OfficerVirginie Beck – Vice President, Strategic Projects & Secretary GeneralBruno Bonnemain – Qualified Person (QP)Claire Corot – Vice President, Research & InnovationPierre Courteille – Vice President, Sales & MarketingPierre Desché – Vice President, Development, Medical and Regulatory AffairsBrigitte Gayet – Chief Manufacturing Quality OfficerHenri-François Gregy – Vice President, PharmaceuticalsJean-François Le Martret – Chief Financial and Administrative OfficerPascal Mailliart – Vice President, Human ResourcesDominique Meyer – Vice President, ChemicalsOlivier Vallet – Chief Supply Chain Officerb) Board of DirectorsJean-Jacques Bertrand – Chairman of the Board of DirectorsMarion BarbierJacques BiotVincent DagommerOlivier GuerbetMarie-Claire Janailhac-FritschChristian Louvet19
c) International presenceRegion Country CompanyGuerbetOwnership interest(%)N/ASimafex 100.00%FranceMedex 60.00% 1Guerbet France 100.00% 2Abalux 100.00% 2Abarem 100.00% 2Germany Guerbet GmbH 100.00%EuropeAustria Guerbet Austria 100.00%Belgium SA Guerbet NV 99.78%Spain Guerbet Laboratorios Farmaceuticos 100.00%Italy Guerbet SpA 99.90%Netherlands Guerbet NLBV 100.00%Portugal A. Martins & Fernandes 100.00%United Kingdom Guerbet Laboratories 100.00%Switzerland Guerbet A.G. 100.00%Turkey Guerbet A.S. 99.99%Brazil Guerbet Produtos Radiologicos 99.99%AmericasMexico Guerbet Mexicana 99.98%United States Guerbet LLC 100.00%Hong Kong Guerbet Asia Pacific 100.00%AsiaSouth Korea Guerbet Korea 100.00%Taiwan Guerbet Taiwan 100.00%Japan Guerbet Japan KK 100.00%d) Industrial assets – list of manufacturing facilitiesEstablishment Address Type of activityAulnay-sous-BoisLanesterMarans (Simafex)Rio de Janeiro16/24 rue Jean Chaptal93600 Aulnay-sous-Bois705 rue Denis Papin56607 Lanester16 rue des Fours-à-Chaux17 320 MaransRua André Rocha,3000 – JacarepaguaCEP 22710 - 561Rio de JaneiroBrazilMain pharmaceutical manufacturing plantResearch laboratoryMain chemicals plantFine chemicalsSecond pharmaceutical manufacturing plantGuerbet is also the operator of its distribution platform based in Gonesse (95).1 Guerbet has a purchase commitment for the minority share of Medex which is accordingly fully consolidated.2 Guerbet France, Abalux and Abarem were created in 2012 and are wholly-owned Guerbet subsidiaries.20
Page 3 and 4: CONTENTSCHIEF EXECUTIVE OFFICERS’
Page 5 and 6: CHIEF EXECUTIVE OFFICERS’ MESSAGE
Page 7 and 8: THE GUERBET GROUP1) History of the
Page 9 and 10: 3) Business overview3.1 Guerbet is
Page 11 and 12: 3.4 The pathologiesIn Oncology, the
Page 13: Guerbet's offering of products is c
Page 16 and 17: c) Research & development• R&D ob
Page 18 and 19: • A proactive partnering strategy
Page 22 and 23: e) DistributionGuerbet distribute i
Page 24 and 25: DirectorsOther offices and director
Page 26 and 27: There exist no arrangements or unde
Page 28 and 29: Summary of compensation for Marie-C
Page 30 and 31: • Stock options granted to non-of
Page 32 and 33: I - 1Organisation of the work of th
Page 34 and 35: "Research and Innovation" Committee
Page 36 and 37: II - Internal control and risk mana
Page 38 and 39: 4) Statutory Auditors’ report pre
Page 40 and 41: SHAREHOLDER INFORMATION1) The Guerb
Page 42 and 43: As at 31 December 2010SHARESVOTING
Page 44 and 45: considered to have automatically re
Page 46 and 47: 10) Provisions of the Articles of A
Page 48 and 49: c) Earnings highlightsIFRS(in thous
Page 50 and 51: g) OutlookStrongly focused on the n
Page 52 and 53: 3) Risk factorsThe company conducte
Page 54 and 55: • Sourcing risksGuerbet has an ex
Page 56 and 57: • Information technology risksAn
Page 58 and 59: • Five-year summary of consolidat
Page 60 and 61: • Other information included in t
Page 62 and 63: • Recruitment and dismissalsGuerb
Page 64 and 65: and employee savings. The goal is s
Page 66 and 67: • Measures adopted to promote emp
Page 68 and 69: ) Pollution and waste managementThe
Page 70 and 71:
3) Societal informationa) Territori
Page 72 and 73:
• Consolidated income statementIn
Page 74 and 75:
In thousands of euros• Statement
Page 76 and 77:
Changes in standards and interpreta
Page 78 and 79:
g) Research and development expendi
Page 80 and 81:
Held to maturity investmentsHeld-to
Page 82 and 83:
creation are recorded under "Other
Page 84 and 85:
III) Notes to the financial stateme
Page 86 and 87:
Aged trial balance information for
Page 88 and 89:
2.2 - Borrowings by currencyCurrenc
Page 90 and 91:
3.3 - Analysis of the sensitivity o
Page 92 and 93:
Revenue2012European companiesfor th
Page 94 and 95:
In 2005, the Group acquired for ¥5
Page 96 and 97:
6.2 - Analysis of property, plant a
Page 98 and 99:
The change in the net value of inve
Page 100 and 101:
12.2 - Accrued employee benefitsa)
Page 102 and 103:
Change in net liabilities of the pe
Page 104 and 105:
14.4 - Personnel by region at year-
Page 106 and 107:
Note 22 - Research and development
Page 108 and 109:
Note 25 - Related parties25.1 - Rel
Page 110 and 111:
Note 27 - Basic earnings per share
Page 112 and 113:
2) Auditors’ report on the consol
Page 114 and 115:
3) Parent company financial stateme
Page 116 and 117:
• Income statementIn thousands of
Page 118 and 119:
• Statement of cash flowsIn milli
Page 120 and 121:
c) Property, plant and equipmentPro
Page 122 and 123:
Note 1 - Intangible assets1 - 1 - C
Page 124 and 125:
Note 6 - Receivables by maturityCos
Page 126 and 127:
Note 9 - Regulated provisionsInvest
Page 128 and 129:
Note 13 - Sales by region2012 2011F
Page 130 and 131:
Tax income or expense recorded in t
Page 132 and 133:
Debt waiver agreements granted to a
Page 134 and 135:
Capital lease commitments relative
Page 136 and 137:
4) Auditors' report on the separate
Page 138 and 139:
5) Auditors' special report on rela
Page 140 and 141:
ORDINARY AND EXTRAORDINARY GENERAL
Page 142 and 143:
RESOLUTION THREE (Special report of
Page 144 and 145:
Extraordinary resolutionsRESOLUTION
Page 146 and 147:
3) Report of the Board of Directors
Page 148 and 149:
Application of legal provisions gov
Page 150 and 151:
• Tenth draft resolution: stock s
Page 152 and 153:
2) The Statutory Auditorsa) Statuto
Page 154 and 155:
6) Articles of association (selecte
Page 156 and 157:
7) 2013 shareholders calendarEventD
Page 158 and 159:
) Annual financial reportInformatio
show all

Read the Registration Document - Guerbet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?